Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference28 articles.
1. Immunological aspects of cancer chemotherapy;Zitvogel;Nat Rev Immunol,2008
2. Immunological aspects of anticancer chemotherapy;Zitvogel;Bull Acad Natl Med,2008
3. NY-ESO-1: review of an immunogenic tumor antigen;Gnjatic;Adv Cancer Res,2006
4. HLA class I-associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine;Bioley;Clin Cancer Res,2009
5. Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1;Le Gal;J Immunother,2005
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Gemcitabine‐Loaded Injectable Hydrogel for Localized Breast Cancer Immunotherapy;Advanced Functional Materials;2024-07-06
2. Immunotherapy for the treatment of biliary tract cancer: an evolving landscape;Therapeutic Advances in Medical Oncology;2024-01
3. Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma;British Journal of Haematology;2023-10-31
4. Redox modulation with a perfluorocarbon nanoparticle to reverse Treg-mediated immunosuppression and enhance anti-tumor immunity;Journal of Controlled Release;2023-06
5. Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators;Cancer Cell;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3